CN103876145A - Probiotics micro-ecological tablet and preparation method thereof - Google Patents
Probiotics micro-ecological tablet and preparation method thereof Download PDFInfo
- Publication number
- CN103876145A CN103876145A CN201410129017.7A CN201410129017A CN103876145A CN 103876145 A CN103876145 A CN 103876145A CN 201410129017 A CN201410129017 A CN 201410129017A CN 103876145 A CN103876145 A CN 103876145A
- Authority
- CN
- China
- Prior art keywords
- probiotic
- tablet
- powder
- bifidobacterium
- bifidobacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 72
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 68
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 57
- 230000000529 probiotic effect Effects 0.000 claims abstract description 55
- 241000894006 Bacteria Species 0.000 claims abstract description 40
- 235000015141 kefir Nutrition 0.000 claims abstract description 38
- 239000007858 starting material Substances 0.000 claims abstract description 36
- 238000000855 fermentation Methods 0.000 claims abstract description 25
- 230000004151 fermentation Effects 0.000 claims abstract description 25
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 18
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 9
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 9
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 9
- 235000020183 skimmed milk Nutrition 0.000 claims description 26
- 239000002609 medium Substances 0.000 claims description 25
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 14
- 239000008101 lactose Substances 0.000 claims description 14
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 12
- 108010046377 Whey Proteins Proteins 0.000 claims description 12
- 102000007544 Whey Proteins Human genes 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000002054 inoculum Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 8
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 7
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- 241001608472 Bifidobacterium longum Species 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 229920001202 Inulin Polymers 0.000 claims description 6
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- 239000005862 Whey Substances 0.000 claims description 6
- 230000004913 activation Effects 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 239000008103 glucose Substances 0.000 claims description 6
- 150000004676 glycans Chemical class 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 6
- 229940029339 inulin Drugs 0.000 claims description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 6
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 6
- 229940099596 manganese sulfate Drugs 0.000 claims description 6
- 239000011702 manganese sulphate Substances 0.000 claims description 6
- 235000007079 manganese sulphate Nutrition 0.000 claims description 6
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 6
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 6
- 229920001542 oligosaccharide Polymers 0.000 claims description 6
- 150000002482 oligosaccharides Chemical class 0.000 claims description 6
- 229920001282 polysaccharide Polymers 0.000 claims description 6
- 239000005017 polysaccharide Substances 0.000 claims description 6
- 229940073490 sodium glutamate Drugs 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 235000021119 whey protein Nutrition 0.000 claims description 6
- 238000001694 spray drying Methods 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 4
- 241000186012 Bifidobacterium breve Species 0.000 claims description 4
- 239000002131 composite material Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 238000003825 pressing Methods 0.000 claims description 3
- 239000003223 protective agent Substances 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000000813 microbial effect Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 238000009475 tablet pressing Methods 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 abstract description 2
- 235000019634 flavors Nutrition 0.000 abstract description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 235000019621 digestibility Nutrition 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 241000208340 Araliaceae Species 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明的一种益生菌微生态片剂及其制备方法,属于保健食品及加工的技术领域。益生菌微生态片剂按质量计为益生菌菌粉90%~98%,低聚果糖1%~9%,硬脂酸镁0.1%~1%。制备是将双歧杆菌进行活化,并制备开菲尔发酵剂;再将二者经混合发酵、低温浓缩干燥、混料压片制得。混合发酵是将益生菌混合菌种进行接种,28~36℃条件下发酵16~24小时,混合菌种中开菲尔发酵剂与双歧杆菌的比例1~3:1。本发明将开菲尔发酵剂和双歧杆菌进行高密度混合发酵,菌种多样,储存稳定,片剂中的活菌数分别达到20亿cfu/g以上;不仅可以提高消化能力,同时还增强了益生菌在肠道中的定植能力;具有营养价值高,风味独特等特点。A probiotic microecological tablet and a preparation method thereof of the present invention belong to the technical field of health food and processing. The probiotic microecological tablet contains 90% to 98% probiotic powder, 1% to 9% fructooligosaccharide and 0.1% to 1% magnesium stearate by mass. The preparation is to activate the bifidobacteria and prepare the kefir starter; then, the two are mixed and fermented, concentrated and dried at low temperature, and mixed and pressed into tablets. Mixed fermentation is to inoculate the mixed strains of probiotics, and ferment for 16-24 hours at 28-36° C., and the ratio of kefir starter to bifidobacteria in the mixed strains is 1-3:1. The present invention carries out high-density mixed fermentation of kefir starter and bifidobacteria, with diverse strains and stable storage, and the number of live bacteria in the tablet reaches more than 2 billion cfu/g respectively; it can not only improve digestibility, but also enhance It improves the colonization ability of probiotics in the intestinal tract; it has the characteristics of high nutritional value and unique flavor.
Description
技术领域technical field
本发明涉及一种益生菌微生态片剂及其制备方法,属于保健食品及加工的技术领域。The invention relates to a probiotic microecological tablet and a preparation method thereof, belonging to the technical field of health food and processing.
背景技术Background technique
益生菌微生态片剂作为益生菌微生态制剂的一种,具有调整肠道菌群,改善人体微生态平衡,抑制有害的病原微生物在人体中的生长繁殖等功效。益生菌微生态片剂中的有效成分为益生菌活菌,目前常见的益生菌有乳酸菌,双歧杆菌,保加利亚乳杆菌,嗜热链球菌等。目前市售的益生菌微生态制剂主要为固体冲剂或胶囊剂,其中含有的益生菌菌粉大多是由单一菌种的菌粉和辅料经过复配后加工而成,菌粉经过多次加工后,菌种活力下降,不足以达到预期的保健效果。As a kind of probiotic microecological preparation, probiotic microecological tablets have the functions of adjusting intestinal flora, improving the microecological balance of the human body, and inhibiting the growth and reproduction of harmful pathogenic microorganisms in the human body. The active ingredients in the probiotic microecological tablet are live probiotics. Currently, common probiotics include lactic acid bacteria, bifidobacteria, Lactobacillus bulgaricus, and Streptococcus thermophilus. At present, the commercially available probiotic microecological preparations are mainly solid granules or capsules, and most of the probiotic powders contained in them are processed from a single strain of bacteria powder and auxiliary materials after compounding. , the vitality of the bacteria decreased, which was not enough to achieve the expected health care effect.
本发明将开菲尔发酵剂和双歧杆菌经高密度培养,混合发酵后,低温浓缩干燥后压片制成益生菌微生态片剂,避免了菌粉的多次加工,提高了益生菌的活菌含量。其次,目前市售的益生菌微生态制剂多为单一菌种复配而成,该微生态片剂含有开菲尔发酵剂中的多种益生菌,并与双歧杆菌混合发酵后制成,丰富了益生菌的种类,提高了产品的保健效果。In the present invention, kefir starter and bifidobacteria are cultured at high density, mixed and fermented, concentrated and dried at low temperature, and then pressed into tablets to make probiotic micro-ecological tablets, which avoids multiple processing of bacterial powder and improves the yield of probiotics. Live bacteria content. Secondly, most of the currently commercially available probiotic microecological preparations are compounded by a single strain of bacteria. It enriches the types of probiotics and improves the health effect of the product.
发明内容Contents of the invention
本发明的目的在于提供一种益生菌微生态片剂及其制备方法,产品含有多种活性益生菌,具有调整肠道菌群平衡,促进消化吸收,增强机体免疫力,治疗腹泻和便秘等功效。The purpose of the present invention is to provide a probiotic microecological tablet and its preparation method. The product contains a variety of active probiotics, which can adjust the balance of intestinal flora, promote digestion and absorption, enhance the body's immunity, and treat diarrhea and constipation. .
本发明是通过以下技术手段来实现的:The present invention is achieved by the following technical means:
一种益生菌微生态片剂,按质量百分比计组分为,益生菌菌粉90%~98%,低聚果糖1%~9%,硬脂酸镁0.1%~1%。The invention relates to a probiotic microecological tablet, which is composed of 90%-98% of probiotic powder, 1%-9% of fructooligosaccharide and 0.1%-1% of magnesium stearate.
上述片剂中,益生菌是由开菲尔发酵剂中的复合菌种和双歧杆菌组成。按质量计开菲尔发酵剂中的的复合菌种︰双歧杆菌=1~3︰1。In the above tablet, the probiotics are composed of composite bacteria and bifidobacteria in the kefir starter. Composite strains in kefir starter by mass: bifidobacteria = 1 ~ 3: 1.
益生菌菌粉是由开菲尔发酵剂中的复合菌种(乳酸菌、酵母菌等)、双歧杆菌经高密度培养,混合发酵,低温浓缩干燥后制得。Probiotic bacteria powder is made from compound bacteria (lactic acid bacteria, yeast, etc.) and bifidobacteria in kefir starter cultured at high density, mixed fermentation, concentrated and dried at low temperature.
上述片剂中,双歧杆菌是由婴儿双歧杆菌、长双歧杆菌、短双歧杆菌、青春双歧杆菌中的1~3种组成。含2~3种双歧杆菌时,各种双歧杆菌的质量比可以随意,具体比例取决于制备中所用的各种活化双歧杆菌混合的比例。In the above tablet, the bifidobacterium is composed of 1 to 3 types of Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium breve and Bifidobacterium adolescent. When 2 to 3 kinds of bifidobacteria are contained, the mass ratio of various bifidobacteria can be arbitrary, and the specific ratio depends on the mixing ratio of various activated bifidobacteria used in the preparation.
上述片剂中,活菌浓度大于60亿cfu/g。In the above tablet, the concentration of viable bacteria is greater than 6 billion cfu/g.
一种益生菌微生态片剂的制备方法,首先使用MRS乳糖培养基将双歧杆菌进行活化,使用脱脂乳接种开菲尔粒制备开菲尔发酵剂;其特征在于,再经混合发酵、低温浓缩干燥、混料压片制得;A method for preparing probiotic microecological tablets, firstly using MRS lactose medium to activate bifidobacteria, using skim milk to inoculate kefir grains to prepare kefir starter; it is characterized in that, after mixed fermentation, low temperature Concentrated and dried, mixed and pressed into tablets;
所述的混合发酵,是按下述过程配制培养基,培养基按重量百分比计的组分有,浓缩乳清蛋白2%~10%,葡萄糖1%~10%,酵母粉0.5%~1%,碳酸钙0.4%~1%,硫酸镁0.01%~0.06%,硫酸锰0.001%~0.01%,乳清粉1%~10%,菊粉0.5%~3%,人参多糖0.04%~1%,大豆低聚糖0.02%~1%,余量为蒸馏水;将各组分溶解于蒸馏水中,调节pH为6.5~7.5,在90~115℃条件下保温10~30min杀菌;冷却至20~30℃将开菲尔发酵剂和双歧杆菌的混合菌种按培养基体积的3%~10%进行接种,在28~36℃条件下,发酵16~24小时,得到益生菌混合发酵液,其中开菲尔发酵剂与双歧杆菌的接种比例为开菲尔发酵剂∶双歧杆菌=1~3:1;The mixed fermentation is to prepare the medium according to the following process. The components of the medium by weight percentage include concentrated whey protein 2% to 10%, glucose 1% to 10%, and yeast powder 0.5% to 1%. , calcium carbonate 0.4%~1%, magnesium sulfate 0.01%~0.06%, manganese sulfate 0.001%~0.01%, whey powder 1%~10%, inulin 0.5%~3%, ginseng polysaccharide 0.04%~1%, Soybean oligosaccharides 0.02% ~ 1%, the balance is distilled water; dissolve each component in distilled water, adjust the pH to 6.5 ~ 7.5, keep it at 90 ~ 115 ° C for 10 ~ 30 minutes to sterilize; cool to 20 ~ 30 ° C Inoculate the mixed strains of kefir starter and bifidobacteria according to 3% to 10% of the medium volume, and ferment for 16 to 24 hours at 28 to 36°C to obtain a mixed fermentation broth of probiotics. The inoculation ratio of Phil starter and Bifidobacteria is Kefir starter: Bifidobacteria=1~3:1;
所述的低温浓缩干燥,是将益生菌混合发酵液在3000~6000r/min条件下,搅拌离心15~30min,收集浓缩菌体;再向浓缩菌体中加入保护剂,预冻后按现有的方法进行真空冷冻干燥或在进风温度为80~120℃,出风温度50~70℃的条件下,进行低温喷雾干燥,得到益生菌菌粉;The low-temperature concentrated drying is to stir and centrifuge the probiotic mixed fermentation liquid for 15-30 minutes under the condition of 3000-6000 r/min, and collect the concentrated bacteria; Vacuum freeze-drying or low-temperature spray-drying under the condition that the inlet air temperature is 80-120°C and the outlet air temperature is 50-70°C, to obtain the probiotic bacteria powder;
所述的混料压片,是按照质量百分比将90%~98%益生菌菌粉、1%~9%低聚果糖、0.1%~1%硬脂酸镁混合均匀,压片制成益生菌微生态片剂。The mixed material pressing is to mix 90%-98% probiotic powder, 1%-9% fructo-oligosaccharide, and 0.1%-1% magnesium stearate evenly according to the mass percentage, and press the tablet to make probiotics Microbial tablet.
最终制成的成品,是单位活菌数大于60亿cfu/g的复合益生菌微生态片剂。The final product is a compound probiotic microecological tablet with a unit viable count greater than 6 billion cfu/g.
所述的双歧杆菌进行活化,可以按现有技术进行,也可以按下述过程进行,将冻存的双歧杆菌菌粉接种于MRS乳糖培养基,37℃培养24h后,经镜检符合双歧杆菌的标准形态,生长状态良好,再按接种量3%~6%接种于MRS乳糖培养基进行活化,37℃培养18~24h。The activation of the bifidobacteria can be carried out according to the prior art, or can be carried out according to the following process. The frozen bifidobacteria powder is inoculated on the MRS lactose medium, and after being cultivated at 37°C for 24 hours, the microscopic examination conforms to The standard form of bifidobacteria is in a good growth state, and then inoculated with 3% to 6% of the inoculum in MRS lactose medium for activation, and cultured at 37°C for 18 to 24 hours.
上述的双歧杆菌菌粉,可以是婴儿双歧杆菌粉、长双歧杆菌粉、短双歧杆菌粉或/和青春双歧杆菌粉;使用2~3种菌粉时,分别活化再按比例混合得到活化的双歧杆菌,用于与开菲尔发酵剂混合发酵。The above-mentioned Bifidobacterium powder can be Bifidobacterium infantis powder, Bifidobacterium longum powder, Bifidobacterium breve powder or/and Bifidobacterium adolescentis powder; Mix to obtain activated bifidobacteria for mixed fermentation with kefir starter.
所述的制备开菲尔发酵剂,可以按现有技术进行,也可以按下述过程进行,使用脱脂乳粉配成10%的脱脂乳溶液,经过90~115℃,10~30min杀菌后,冷却至20~30℃,按照脱脂乳体积的0.1%~0.5%接种开菲尔粒,在23~28℃的条件下发酵14~18h。The preparation of the kefir starter can be carried out according to the prior art, and can also be carried out according to the following process, using skim milk powder to make a 10% skim milk solution, after sterilizing at 90 to 115 ° C for 10 to 30 minutes, Cool to 20-30°C, inoculate kefir grains according to 0.1%-0.5% of the volume of skim milk, and ferment at 23-28°C for 14-18 hours.
在低温浓缩干燥过程中,所述的保护剂,是按益生菌混合发酵液重量为基数,由脱脂乳粉10%~20%、海藻糖1%~10%、谷氨酸钠1%~10%、甘油1%~5%组成。In the low-temperature concentration and drying process, the protective agent is based on the weight of the probiotic mixed fermentation broth, consisting of 10% to 20% of skim milk powder, 1% to 10% of trehalose, and 1% to 10% of sodium glutamate. %, glycerin 1% to 5%.
在混料压片过程中,所述的压片,可以利用压片机,在压力为4000~10000N条件下进行。可以压成直径6~12mm、片重0.3~0.5g、硬度8~10kg/cm2的片剂。In the mixing and tableting process, the tableting can be carried out by using a tableting machine under the condition of a pressure of 4000-10000N. It can be pressed into tablets with a diameter of 6-12mm, a tablet weight of 0.3-0.5g, and a hardness of 8-10kg/ cm2 .
本发明的有益效果在于:The beneficial effects of the present invention are:
1)本发明将开菲尔发酵剂和双歧杆菌进行高密度混合发酵,菌种多样,储存稳定,片剂中的活菌数可分别达到20亿cfu/g以上;1) In the present invention, kefir starter and bifidobacteria are mixed and fermented at high density, with various strains and stable storage, and the number of viable bacteria in the tablet can reach more than 2 billion cfu/g respectively;
2)开菲尔发酵剂和双歧杆菌混合发酵后,不仅可以提高消化能力,同时还增强了益生菌在肠道中的定植能力,丰富了肠道菌群,改善了肠道的微生态平衡,对维持肠道健康有着良好的效果;2) The mixed fermentation of kefir starter and bifidobacteria can not only improve the digestion ability, but also enhance the colonization ability of probiotics in the intestine, enrich the intestinal flora, improve the micro-ecological balance of the intestinal tract, It has a good effect on maintaining intestinal health;
3)本发明含有丰富的益生菌及其活性代谢产物,并添加了低聚果糖,具有营养价值高,风味独特等特点。3) The present invention contains abundant probiotics and their active metabolites, and adds fructooligosaccharides, which has the characteristics of high nutritional value and unique flavor.
具体实施方式Detailed ways
以下实施例是对本发明的进一步说明,而不是对本发明的限制。The following examples are to further illustrate the present invention, rather than limit the present invention.
实施例1:Example 1:
1)益生菌发酵剂的制备1) Preparation of probiotic starter
①双歧杆菌的制备① Preparation of bifidobacteria
将冻存的青春双歧杆菌菌粉接种于MRS乳糖培养基,37℃,培养24h后,经镜检符合双歧杆菌的标准形态,生长状态良好,按接种量3%接种于MRS乳糖培养基进行活化,37℃,培养24h保存备用。Inoculate the frozen Bifidobacterium adolescent powder into MRS lactose medium, culture at 37°C for 24 hours, and the microscopic examination conforms to the standard form of bifidobacteria, and the growth state is good. Inoculate 3% of the inoculum into MRS lactose medium For activation, culture at 37°C for 24 hours and save for later use.
②开菲尔发酵剂的制备② Preparation of Kefir starter
使用脱脂乳粉配成10%的脱脂乳溶液,经过115℃,30min杀菌后,冷却至25℃,按照脱脂乳体积的0.1%接种开菲尔粒,在23℃的条件下发酵18h后保存备用。Use skim milk powder to make 10% skim milk solution, after sterilizing at 115°C for 30 minutes, cool to 25°C, inoculate kefir grains with 0.1% of the volume of skim milk, ferment at 23°C for 18 hours and store for later use .
2)混合发酵2) Mixed fermentation
取浓缩乳清蛋白10g,葡萄糖6.7g,酵母粉3.8g,碳酸钙3.4g,硫酸镁0.2g,硫酸锰0.015g,乳清粉14g,菊粉2.5g,人参多糖0.5g,大豆低聚糖1g,加入蒸馏水至总质量为500g。充分溶解后调节培养基pH为7.0,杀菌条件为115℃条件下保温30min,冷却至30℃备用。Take concentrated whey protein 10g, glucose 6.7g, yeast powder 3.8g, calcium carbonate 3.4g, magnesium sulfate 0.2g, manganese sulfate 0.015g, whey powder 14g, inulin 2.5g, ginseng polysaccharide 0.5g, soybean oligosaccharide 1g, add distilled water to a total mass of 500g. After fully dissolving, adjust the pH of the medium to 7.0, and the sterilization condition is to keep warm at 115°C for 30 minutes, and cool to 30°C for later use.
向冷却后的高密度培养基接种,按3%接种量,开菲尔发酵剂:青春双歧杆菌=2:1,28℃,发酵24h。Inoculate the cooled high-density medium with 3% inoculum, kefir starter: Bifidobacterium adolescent = 2:1, 28°C, and ferment for 24 hours.
3)菌粉的制备3) Preparation of bacteria powder
将制得的发酵液搅拌均匀,在20℃条件下,转速为6000转/分,时间为15min离心处理,收集浓缩菌体;离心收集的菌体,添加脱脂乳粉10%、海藻糖5%、谷氨酸钠1%、甘油3%,混合均匀,无菌水调整干物质浓度在30~40%,在进风温度为80~120℃,出风温度50~70℃的条件下,进行低温喷雾干燥,得到益生菌菌粉。Stir the fermented broth evenly, and centrifuge at 6000 rpm for 15 minutes at 20°C to collect concentrated bacteria; add 10% skim milk powder and 5% trehalose to the collected bacteria , 1% sodium glutamate, 3% glycerin, mix evenly, adjust the dry matter concentration to 30-40% with sterile water, and carry out under the condition that the air inlet temperature is 80-120°C and the outlet air temperature is 50-70°C. Low-temperature spray drying to obtain probiotic bacteria powder.
4)压片4) Tablet
按照质量百分比将98%益生菌菌粉,1.5%低聚果糖,0.5%硬脂酸镁混合均匀,然后利用压片机,在压力为4000N条件下压片,制成益生菌微生态片剂。其中,片剂的直径为8mm,片重:0.3g,硬度:8kg/cm2。微生态片剂的技术指标为:乳酸菌数≥30亿cfu/g,酵母菌≥20亿cfu/g,双歧杆菌≥20亿cfu/g。Mix 98% probiotic powder, 1.5% fructooligosaccharide, and 0.5% magnesium stearate uniformly according to the mass percentage, and then use a tablet machine to compress the tablet under a pressure of 4000N to make a probiotic microecological tablet. Wherein, the diameter of the tablet is 8 mm, the tablet weight: 0.3 g, and the hardness: 8 kg/cm 2 . The technical indicators of microecological tablets are: the number of lactic acid bacteria ≥ 3 billion cfu/g, the number of yeast ≥ 2 billion cfu/g, and the number of bifidobacteria ≥ 2 billion cfu/g.
实施例2Example 2
1)益生菌发酵剂的制备1) Preparation of probiotic starter
①双歧杆菌的制备① Preparation of bifidobacteria
将冻存的青春双歧杆菌菌粉和婴儿双歧杆菌菌粉分别接种于MRS乳糖培养基,37℃,培养24h后,经镜检符合双歧杆菌的标准形态,生长状态良好,按接种量5%,分别接种于MRS乳糖培养基进行活化,37℃,培养20h。将青春双歧杆菌和婴儿双歧杆菌按照体积比1:1混合,保存备用。Inoculate the frozen Bifidobacterium adolescent powder and Bifidobacterium infantis powder into MRS lactose medium respectively, culture at 37°C for 24 hours, and the microscopic examination conforms to the standard form of Bifidobacterium, and the growth state is good. 5%, were inoculated in MRS lactose medium for activation, 37 ℃, cultured for 20h. Mix Bifidobacterium adolescentis and Bifidobacterium infantis in a volume ratio of 1:1, and save for future use.
②开菲尔发酵剂的制备② Preparation of Kefir starter
使用脱脂乳粉配成10%的脱脂乳溶液,经过115℃,30min杀菌后,冷却至23℃,按照脱脂乳体积的0.3%接种开菲尔直投式发酵剂,在26℃的条件下发酵16h后保存备用。Use skim milk powder to make 10% skim milk solution, after sterilizing at 115°C for 30 minutes, cool to 23°C, inoculate kefir direct-throwing starter at 0.3% of the volume of skim milk, and ferment at 26°C Save for later use after 16 hours.
2)混合发酵2) Mixed fermentation
取浓缩乳清蛋白18g,葡萄糖5g,酵母粉4.29g,碳酸钙4.0g,硫酸镁0.3g,硫酸锰0.027g,乳清粉10g,菊粉5g,人参多糖1g,大豆低聚糖0.5g,加入蒸馏水至总质量为500g。充分溶解后调节培养基pH为7.0,杀菌条件为115℃条件下保温20min,冷却至25℃备用。Take concentrated whey protein 18g, glucose 5g, yeast powder 4.29g, calcium carbonate 4.0g, magnesium sulfate 0.3g, manganese sulfate 0.027g, whey powder 10g, inulin 5g, ginseng polysaccharide 1g, soybean oligosaccharide 0.5g, Add distilled water to a total mass of 500 g. After fully dissolving, adjust the pH of the medium to 7.0, and the sterilization conditions are 115°C for 20 minutes, then cool to 25°C for later use.
向冷却后的高密度培养基接种,按5%接种量,开菲尔发酵剂:双歧杆菌=1:1,30℃,发酵20h。Inoculate the cooled high-density medium with 5% inoculum, kefir starter: bifidobacteria = 1:1, 30°C, and ferment for 20 hours.
3)菌粉的制备3) Preparation of bacteria powder
将制得的发酵液搅拌均匀,在15℃条件下,转速为4000转/分,时间为20min离心处理,收集浓缩菌体;离心收集的菌体,添加脱脂乳粉15%、海藻糖1%、谷氨酸钠7%、甘油5%,混合均匀,预冻8h后,放入低温冷冻干燥机中干燥24h后,得到益生菌菌粉。Stir the fermented broth evenly, and centrifuge at 4000 rpm for 20 minutes at 15°C to collect concentrated bacteria; add 15% skimmed milk powder and 1% trehalose to the bacteria collected by centrifugation , 7% sodium glutamate, and 5% glycerin, mixed evenly, pre-frozen for 8 hours, and dried in a low-temperature freeze dryer for 24 hours to obtain probiotic powder.
4)压片4) Tablet
按照质量百分比将96%益生菌菌粉,3%低聚果糖,1%硬脂酸镁混合均匀,然后利用压片机,在压力为6000N条件下压片,制成益生菌微生态片剂。其中,片剂的直径为10mm,片重:0.4g,硬度:9kg/cm2。微生态片剂的技术指标为:乳酸菌数≥30亿cfu/g,酵母菌≥20亿cfu/g,双歧杆菌≥20亿cfu/g。Mix 96% probiotic bacteria powder, 3% fructooligosaccharide, and 1% magnesium stearate uniformly according to the mass percentage, and then use a tablet machine to compress the tablet under a pressure of 6000N to make a probiotic microecological tablet. Wherein, the diameter of the tablet is 10 mm, the tablet weight: 0.4 g, and the hardness: 9 kg/cm 2 . The technical indicators of microecological tablets are: the number of lactic acid bacteria ≥ 3 billion cfu/g, the number of yeast ≥ 2 billion cfu/g, and the number of bifidobacteria ≥ 2 billion cfu/g.
实施例3Example 3
1)益生菌发酵剂的制备1) Preparation of probiotic starter
①双歧杆菌的制备① Preparation of bifidobacteria
将冻存的青春双歧杆菌菌粉,长双歧杆菌菌粉和婴儿双歧杆菌菌粉分别接种于MRS乳糖培养基,37℃,培养24h后,经镜检符合双歧杆菌的标准形态,生长状态良好,按接种量6%,分别接种于MRS乳糖培养基进行活化,37℃,培养20h。将青春双歧杆菌,长双歧杆菌和婴儿双歧杆菌按照体积比2:1:1混合,保存备用。The frozen Bifidobacterium adolescent powder, Bifidobacterium longum powder and Bifidobacterium infantis powder were respectively inoculated in MRS lactose medium at 37°C. After culturing for 24 hours, the standard form of Bifidobacterium was found by microscope inspection. The growth state is good, according to the inoculum size of 6%, inoculated in MRS lactose medium for activation, 37 ℃, cultured for 20h. Mix Bifidobacterium adolescentis, Bifidobacterium longum and Bifidobacterium infantis in a volume ratio of 2:1:1, and store for later use.
②开菲尔发酵剂的制备② Preparation of Kefir starter
使用脱脂乳粉配成10%的脱脂乳溶液,经过115℃,20min杀菌后,冷却至20℃,按照脱脂乳体积的0.5%接种开菲尔直投式发酵剂,在28℃的条件下发酵14h后保存备用。Use skim milk powder to prepare 10% skim milk solution, after sterilizing at 115°C for 20 minutes, cool to 20°C, inoculate 0.5% of the volume of skim milk with kefir starter, and ferment at 28°C Save for later use after 14 hours.
2)混合发酵2) Mixed fermentation
取浓缩乳清蛋白20g,葡萄糖8.0g,酵母粉5g,碳酸钙4g,硫酸镁0.1g,硫酸锰0.020g,乳清粉10g,菊粉7g,人参多糖0.2g,大豆低聚糖0.1g,加入蒸馏水至总质量为500g。充分溶解后调节培养基pH为7.0,杀菌条件为95℃条件下保温30min,冷却至25℃备用。Take concentrated whey protein 20g, glucose 8.0g, yeast powder 5g, calcium carbonate 4g, magnesium sulfate 0.1g, manganese sulfate 0.020g, whey powder 10g, inulin 7g, ginseng polysaccharide 0.2g, soybean oligosaccharide 0.1g, Add distilled water to a total mass of 500 g. After fully dissolving, adjust the pH of the medium to 7.0, and the sterilization conditions are 95°C for 30 minutes, then cool to 25°C for later use.
向冷却后的高密度培养基接种,按6%接种量,开菲尔发酵剂:双歧杆菌=3:1,32℃,发酵18h。Inoculate the cooled high-density medium with 6% inoculum, kefir starter: bifidobacteria = 3:1, 32°C, and ferment for 18 hours.
3)菌粉的制备3) Preparation of bacteria powder
将制得的发酵液搅拌均匀,在10℃条件下,转速为3000转/分,时间为30min离心处理,收集浓缩菌体;离心收集的菌体,添加脱脂乳粉20%、海藻糖6%、谷氨酸钠5%、甘油1%,混合均匀,无菌水调整干物质浓度在30~40%,在进风温度为80~120℃,出风温度50~70℃的条件下,进行低温喷雾干燥,得到益生菌菌粉。Stir the fermented broth evenly, and centrifuge at 3000 rpm for 30 minutes at 10°C to collect concentrated bacteria; add 20% skim milk powder and 6% trehalose to the bacteria collected by centrifugation , 5% sodium glutamate, 1% glycerin, mix evenly, adjust the dry matter concentration to 30-40% with sterile water, and carry out under the condition that the air inlet temperature is 80-120°C and the outlet air temperature is 50-70°C. Low-temperature spray drying to obtain probiotic bacteria powder.
4)压片4) Tablet
按照质量百分比将95%益生菌菌粉,4.7%低聚果糖,0.3%硬脂酸镁混合均匀,然后利用压片机,在压力为8000N条件下压片,制成益生菌微生态片剂。其中,片剂的直径为12mm,片重:0.5g,硬度:10kg/cm2。微生态片剂的技术指标为:乳酸菌数≥30亿cfu/g,酵母菌≥20亿cfu/g,双歧杆菌≥20亿cfu/g。Mix 95% probiotic bacteria powder, 4.7% fructooligosaccharide, and 0.3% magnesium stearate evenly according to the mass percentage, and then use a tablet machine to compress the tablet under a pressure of 8000N to make a probiotic microecological tablet. Wherein, the diameter of the tablet is 12 mm, the tablet weight: 0.5 g, and the hardness: 10 kg/cm 2 . The technical indicators of microecological tablets are: the number of lactic acid bacteria ≥ 3 billion cfu/g, the number of yeast ≥ 2 billion cfu/g, and the number of bifidobacteria ≥ 2 billion cfu/g.
实施例4Example 4
按下述用料和工艺条件均可制得本发明的益生菌微生态片剂。The probiotic microecological tablet of the present invention can be obtained according to the following materials and process conditions.
1)益生菌发酵剂的制备1) Preparation of probiotic starter
①双歧杆菌的制备① Preparation of bifidobacteria
将冻存的双歧杆菌菌粉接种于MRS乳糖培养基,37℃,培养24h后,经镜检符合双歧杆菌的标准形态,生长状态良好,按接种量3%~6%接种于MRS乳糖培养基进行活化,37℃,培养18~24h保存备用。Inoculate the frozen bifidobacteria powder in MRS lactose medium, culture at 37°C for 24 hours, and the microscopic examination conforms to the standard form of bifidobacteria, and the growth state is good. Inoculate 3% to 6% of the inoculum in MRS lactose The culture medium was activated, cultured at 37°C for 18-24 hours and stored for later use.
②开菲尔发酵剂的制备② Preparation of Kefir starter
使用脱脂乳粉配成10%的脱脂乳溶液,经过90~115℃,10~30min杀菌后,冷却至20~30℃,按照脱脂乳体积的0.1%~0.5%接种开菲尔粒,在23~28℃的条件下发酵14~18h后保存备用。Use skim milk powder to prepare 10% skim milk solution, after sterilizing at 90-115°C for 10-30 minutes, cool to 20-30°C, inoculate kefir grains according to 0.1%-0.5% of the volume of skim milk, at 23 Ferment at ~28°C for 14-18 hours and store for later use.
2)混合发酵2) Mixed fermentation
取浓缩乳清蛋白10~20g,葡萄糖6~10g,酵母粉3~5g,碳酸钙1~5g,硫酸镁0.05~0.3g,硫酸锰0.01~0.05g,乳清粉5~15g,菊粉2.5~5g,人参多糖0.5~5g,大豆低聚糖0.5~5g,加入蒸馏水至总质量为500g。充分溶解后调节培养基pH为6.5~7.5,杀菌条件为90~115℃条件下保温10~30min,冷却至20~30℃备用。Take concentrated whey protein 10-20g, glucose 6-10g, yeast powder 3-5g, calcium carbonate 1-5g, magnesium sulfate 0.05-0.3g, manganese sulfate 0.01-0.05g, whey powder 5-15g, inulin 2.5g ~5g, 0.5~5g ginseng polysaccharide, 0.5~5g soybean oligosaccharide, add distilled water until the total mass is 500g. After fully dissolving, adjust the pH of the medium to 6.5-7.5, and the sterilization conditions are 90-115°C for 10-30 minutes, then cool to 20-30°C for later use.
向冷却后的培养基接种,按3%~10%接种量,开菲尔发酵剂︰双歧杆菌=1~3︰1,28~36℃,发酵18~24h,得到益生菌混合发酵液。Inoculate the cooled culture medium with an inoculum amount of 3% to 10%, kefir starter: bifidobacteria = 1 to 3:1, 28 to 36°C, and ferment for 18 to 24 hours to obtain a mixed fermentation broth of probiotics.
3)菌粉的制备3) Preparation of bacteria powder
将制得的发酵液搅拌均匀,在10~20℃条件下,转速为3000~6000转/分,时间为10~30min离心处理,收集浓缩菌体;离心收集的菌体,按发酵液体积计添加脱脂乳粉10%~15%、海藻糖1%~5%、谷氨酸钠1%~5%、甘油1%~3%,混合均匀,预冻后进行低温冷冻干燥或在进风温度为80~120℃,出风温度50~70℃的条件下,进行低温喷雾干燥,得到益生菌菌粉。Stir the prepared fermentation broth evenly, and centrifuge at 10-20°C at a speed of 3000-6000 rpm for 10-30 minutes to collect concentrated bacteria; the bacteria collected by centrifugation are calculated according to the volume of the fermentation broth Add 10% to 15% of skimmed milk powder, 1% to 5% of trehalose, 1% to 5% of sodium glutamate, and 1% to 3% of glycerin, mix well, and freeze-dry at low temperature after pre-freezing or at the inlet temperature Under the conditions of 80-120° C. and an outlet air temperature of 50-70° C., low-temperature spray drying is carried out to obtain probiotic bacteria powder.
4)压片4) Tablet
按照质量百分比将90%~98%益生菌菌粉,1%~9%低聚果糖,0.1%~1%硬脂酸镁混合均匀,然后利用压片机,在压力为4000~10000N条件下压片,制成单位活菌数大于60亿cfu/g的复合益生菌微生态片剂。其中,片剂的直径为6~12mm,片重:0.3~0.5g,硬度:8~10kg/cm2。According to the mass percentage, mix 90%-98% probiotic powder, 1%-9% fructooligosaccharide, and 0.1%-1% magnesium stearate evenly, and then use a tablet machine to press under the condition of a pressure of 4000-10000N. Tablets, made into compound probiotic microecological tablets with unit viable bacteria count greater than 6 billion cfu/g. Wherein, the diameter of the tablet is 6-12 mm, the tablet weight: 0.3-0.5 g, and the hardness: 8-10 kg/cm 2 .
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410129017.7A CN103876145B (en) | 2014-04-01 | 2014-04-01 | A kind of probiotics micro-ecological tablet and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410129017.7A CN103876145B (en) | 2014-04-01 | 2014-04-01 | A kind of probiotics micro-ecological tablet and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103876145A true CN103876145A (en) | 2014-06-25 |
CN103876145B CN103876145B (en) | 2016-06-01 |
Family
ID=50945529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410129017.7A Active CN103876145B (en) | 2014-04-01 | 2014-04-01 | A kind of probiotics micro-ecological tablet and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103876145B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758318A (en) * | 2015-03-06 | 2015-07-08 | 山东宝来利来生物工程股份有限公司 | A composite preparation for reducing a diarrhea rate of weaned piglets and a preparing method thereof |
CN104904859A (en) * | 2015-04-21 | 2015-09-16 | 华南农业大学 | Bean yoghourt fermenting agent with processing suitability as well as preparation method and application thereof |
CN106579457A (en) * | 2016-12-30 | 2017-04-26 | 天津替代医学科技股份有限公司 | Butyric acid bacterium probiotic acid slice and preparation method thereof |
CN108523133A (en) * | 2018-03-28 | 2018-09-14 | 广州富诺营养科技有限公司 | A kind of probiotics composite particles and preparation method thereof |
CN111214524A (en) * | 2020-03-18 | 2020-06-02 | 北京中医药大学 | Use of ginseng fermented product |
CN111956676A (en) * | 2020-08-24 | 2020-11-20 | 天津现代创新中药科技有限公司 | A microecological preparation containing Ginseng radix extract and probiotic bacteria, and its preparation method and application |
CN112535214A (en) * | 2020-12-03 | 2021-03-23 | 石家庄君乐宝乳业有限公司 | Probiotic milk tablet with intestine regulating effect and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2100936C1 (en) * | 1996-02-28 | 1998-01-10 | Нина Ивановна Бевз | Method of preparing the ferment for making the curative-prophylactic lactic acid product and a method of its making |
CN1911118A (en) * | 2006-08-18 | 2007-02-14 | 中国农业大学 | Kefir mushroom freeze-dried powder, prodn. method and use thereof |
CN101541194A (en) * | 2006-09-27 | 2009-09-23 | 利特尔卡鲁梅控股有限公司 | Probiotic oral dosage forms |
CN101559082A (en) * | 2009-06-01 | 2009-10-21 | 天津科技大学 | Method for preparing probiotic preparation for reducing blood lipid and adjusting intestinal flora |
CN102986869A (en) * | 2012-12-28 | 2013-03-27 | 石家庄君乐宝乳业有限公司 | Solid Kefir dairy product and preparation method thereof |
-
2014
- 2014-04-01 CN CN201410129017.7A patent/CN103876145B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2100936C1 (en) * | 1996-02-28 | 1998-01-10 | Нина Ивановна Бевз | Method of preparing the ferment for making the curative-prophylactic lactic acid product and a method of its making |
CN1911118A (en) * | 2006-08-18 | 2007-02-14 | 中国农业大学 | Kefir mushroom freeze-dried powder, prodn. method and use thereof |
CN101541194A (en) * | 2006-09-27 | 2009-09-23 | 利特尔卡鲁梅控股有限公司 | Probiotic oral dosage forms |
CN101559082A (en) * | 2009-06-01 | 2009-10-21 | 天津科技大学 | Method for preparing probiotic preparation for reducing blood lipid and adjusting intestinal flora |
CN102986869A (en) * | 2012-12-28 | 2013-03-27 | 石家庄君乐宝乳业有限公司 | Solid Kefir dairy product and preparation method thereof |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104758318A (en) * | 2015-03-06 | 2015-07-08 | 山东宝来利来生物工程股份有限公司 | A composite preparation for reducing a diarrhea rate of weaned piglets and a preparing method thereof |
CN104904859A (en) * | 2015-04-21 | 2015-09-16 | 华南农业大学 | Bean yoghourt fermenting agent with processing suitability as well as preparation method and application thereof |
CN104904859B (en) * | 2015-04-21 | 2018-07-31 | 华南农业大学 | A kind of Sourbean milk fits property leavening processed and its preparation method and application |
CN106579457A (en) * | 2016-12-30 | 2017-04-26 | 天津替代医学科技股份有限公司 | Butyric acid bacterium probiotic acid slice and preparation method thereof |
CN108523133A (en) * | 2018-03-28 | 2018-09-14 | 广州富诺营养科技有限公司 | A kind of probiotics composite particles and preparation method thereof |
CN111214524A (en) * | 2020-03-18 | 2020-06-02 | 北京中医药大学 | Use of ginseng fermented product |
CN111956676A (en) * | 2020-08-24 | 2020-11-20 | 天津现代创新中药科技有限公司 | A microecological preparation containing Ginseng radix extract and probiotic bacteria, and its preparation method and application |
CN112535214A (en) * | 2020-12-03 | 2021-03-23 | 石家庄君乐宝乳业有限公司 | Probiotic milk tablet with intestine regulating effect and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103876145B (en) | 2016-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103876145B (en) | A kind of probiotics micro-ecological tablet and its preparation method | |
CN102742659B (en) | Probiotic goat milk tablet and preparation method of probiotic goat milk tablet | |
CN101731511B (en) | Probiotic active product and preparation method thereof | |
CN103109930A (en) | Fruity probiotic yogurt slice containing antifreeze sericin peptide and method for preparing same | |
CN103766486B (en) | A kind of milky-drinks containing bifidus bacillus embedding pearl and preparation method thereof | |
CN102258081A (en) | Synbiotics liquid goat milk beverage and preparation method thereof | |
CN112553128B (en) | Freeze-dried probiotic powder and its preparation method and application | |
CN104095180A (en) | Probiotics inulin sheet and preparation method thereof | |
CN107287136A (en) | A kind of preparation method of the prebiotic solid lactic acid bacteria agent with prebiotic function | |
CN102258082A (en) | Coagulating probiotic goat yoghurt and preparation method thereof | |
CN103875922B (en) | A kind of composite probiotics micro-ecological additive agent for feeding and preparation method thereof | |
CN1911118A (en) | Kefir mushroom freeze-dried powder, prodn. method and use thereof | |
CN108782758A (en) | A kind of fermented type synbiotic goat milk powder and preparation method thereof | |
CN102524794B (en) | Preparation method of serum cholesterol reduction Kluyveromyces marxianus freeze-dried powder | |
CN108271382A (en) | Microorganism dries the manufacturing method of thalline | |
CN109329699A (en) | A kind of probiotic sea buckthorn puree jelly and preparation method thereof | |
CN104328076A (en) | Preparation method of lactobacillus paracasei probiotics tablet of bifidobacteria producing bile salt hydrolase | |
CN114403231A (en) | A kind of active probiotic solid beverage and preparation method thereof | |
CN110577907A (en) | A kind of animal bifidobacteria and application thereof | |
CN104719467B (en) | A kind of preparation method of Yoghourt | |
JP6343817B2 (en) | Yogurt containing lactic acid bacteria derived from Ishikawa Prefecture's traditional seafood fermented foods | |
CN102586137B (en) | Method for preparing bile salt hydrolase lactobacillus powder starter | |
CN110742124A (en) | Method for improving comprehensive bacteriostatic ability of milk wine fermentation liquor | |
CN108095077B (en) | A kind of method that utilizes probiotics to prepare bamboo shoots enzyme powder | |
CN103184183A (en) | Preparation method of lactobacillus casei dry powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180321 Address after: 132300 Jilin city of Jilin province Panshi City, Fukang Road No. 1456 Patentee after: Jilin province Shunxing Tang Biotechnology Co. Ltd. Address before: 130012 Changchun Qianjin Street, Jilin, No. 2699 Patentee before: Jilin University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180712 Address after: 130000 Jilin Jilin high tech Zone Jifeng East Road 82 production plant Patentee after: Jilin Shun Hong hall biological science and Technology Co., Ltd. Address before: 132300 No. 1456 Fukang Road, Panshi City, Jilin Province Patentee before: Jilin province Shunxing Tang Biotechnology Co. Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211215 Address after: 132300 301, third floor, entrepreneurship Park, Panshi Economic Development Zone, Jilin City, Jilin Province Patentee after: Jilin province Shunxing Tang Biotechnology Co.,Ltd. Address before: 130000 Jilin Jilin high tech Zone Jifeng East Road 82 production plant Patentee before: Jilin Shun Hong hall biological science and Technology Co.,Ltd. |
|
TR01 | Transfer of patent right |